Aims: Metabolic syndrome (MetS) is characterized by a group of defects of metabolic origin which are possibly involved in mitochondrial DNA (mtDNA) alteration of mtDNA content [Lee et al. Exp Biol Med, 2007; 232(5):592-606]. The present study was undertaken to ascertain whether alteration of leukocyte mtDNA copy number is related to MetS. Methods: Eighty non-MetS subjects and 50 subjects with MetS were recruited. The mtDNA copy number of leukocytes from each group of subjects was measured using quantitative polymerase chain reaction. Results: The mtDNA copy number of leukocytes in subjects with MetS was significantly lower than that of non-MetS subjects. Depleted mtDNA copy number is correlated with lower plasma HDL, higher triglyceride, higher HOMA-IR and hypertension, and is even more sensitive to MetS criteria. Conclusions: Depleted leukocyte mtDNA copy number is related to the severity of MetS. Alteration of mtDNA copy number in leukocytes is proposed as a MetS biomarker involved in the bioenergetic change of mitochondria.
CITATION STYLE
Huang, C. H., Su, S. L., Hsieh, M. C., Cheng, W. L., Chang, C. C., Wu, H. L., … Liu, C. S. (2011). Depleted leukocyte mitochondrial DNA copy number in metabolic syndrome. Journal of Atherosclerosis and Thrombosis, 18(10), 867–873. https://doi.org/10.5551/jat.8698
Mendeley helps you to discover research relevant for your work.